Scientists recreate DNA damage caused by toxins from smoking

April 28, 2020

Researchers from the University of York have recreated how toxins from smoking cause unique patterns of DNA damage. The discovery could help scientists better understand the cause of bladder cancer and the link to smoking.

The causes of bladder cancer remain largely unknown, however smoking is seen as the main risk factor for the disease.

Researchers - led by Dr Simon Baker from the Department of Biology - grew human bladder tissues in the laboratory and exposed them to a common toxin from cigarette smoke. After the tissues were damaged by the smoke toxin, the team analysed all three billion letters of the genetic code (DNA) to find a pattern of changes called a "mutational signature."

Dr Baker said: "Mutational signatures can be used like fingerprints at a crime scene. When we look at the DNA in a cancer we can see the fingerprints of all the criminals involved in causing the damage that led to cancer.

"The DNA damaging event might be exposure to cigarette smoke or UV from the sun but it might also be an unknown event that causes cancer."

"Our study found that the smoke toxin left its distinctive fingerprints on the DNA of bladder tissues grown in the laboratory. However, when we looked at the DNA of patients' bladder cancers the mutational signature, of the smoke toxin, was only responsible for a small amount of the damage.

"So despite smoking being the key risk factor for bladder cancer, direct damage of the DNA by smoke toxins is unlikely to be the main reason for these cancers forming."

It may be that the smoke toxins accelerate other DNA damaging events and attention is now focussing on a family of enzymes called "APOBEC".

APOBEC enzymes destroy viruses by mutating their DNA as part of the body's natural defences against infection, but recent studies suggest they might mistakenly target our own DNA in a number of cancer types. The next stage of the study will be to try and understand how and why APOBEC enzymes become activated in the cells of the bladder.
-end-
The paper, "Procarcinogen Activation and Mutational Signatures Model the 4 Initiation of Carcinogenesis in Human Urothelial Tissues In Vitro" is published in European Urology

University of York

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.